Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites

Parasitology Research

Volumn 110, Issue 3, 2012, Pages 1277-1285

  Oliveira, Dulcilene M ^a   Costa, Mariana Amália F ^a   Chavez Fumagalli, Miguel A ^a   Valadares, Diogo G ^a   Duarte, Mariana C ^a   Costa, Lourena E ^a   Martins, Vivian T ^a   Gomes, Rosângela F ^a   Melo, Maria N ^a   Soto, Manuel ^b   Tavares, Carlos Alberto P ^a   Coelho, Eduardo Antonio F ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; NITRIC OXIDE; CYTOKINE; PROTOZOON ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; INOCULATION; LEISHMANIA CHAGASI; LIVER; LYMPHATIC DRAINAGE; MOUSE; NONHUMAN; PARAMETERS; PARASITE LOAD; PARASITOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROMASTIGOTE; SPLEEN; SPLEEN CELL; TH2 CELL; VISCERAL LEISHMANIASIS; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LEISHMANIA INFANTUM; PARASITOLOGY; PATHOGENICITY; PHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; TIME;

ANIMALIA; LEISHMANIA DONOVANI CHAGASI; MUS;

ANIMALS; ANTIBODIES, PROTOZOAN; CYTOKINES; FEMALE; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PARASITE LOAD; TIME FACTORS;

EID: 84862734569     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-011-2628-5     Document Type: Article

References (45)

1. Abreu-Silva AL, Calabrese KS, Tedesco RC, Mortara RA, Costa SCG (2003) Central nervous system involvement in experimental infection with Leishmania (Leishmania) amazonensis. Am J Trop Med Hyg 68:661-665 (Pubitemid 38235093)
2. Afonso LC, Scott P (1993) Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun 61:2952-2959 (Pubitemid 23182292)
3. Afrin F, Anam K, Ali N (2000) Induction of partial protection against Leishmania donovani by promastigoyes antigens in negatively charged liposomes. J Parasitol 89:730-735 (Pubitemid 30646586)
4. Ahmed S, ColmenaresM, Soong L, Goldsmith-Pestana K, Munstermann L, Molina R,McMahon-Pratt D (2003) Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect Immun 71:401-410 (Pubitemid 36026044)
5. Barral A, Pedral-Sampaio D, Grimaldi G Jr., Momen H, McMahon-Pratt D, Ribeiro-de-Jesus A, Almeida R, Badaró R, Barral-Netto M, Carvalho EM, Johnson WD Jr. (1991) Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44:536-546
6. Basu R, Bhaumik S, Haldar AK, Naskar K, De T, Dana SK, Walden P, Roy S (2007) Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic Tlymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13. Infect Immun 75:5956-5966 (Pubitemid 350207836)
7. Bhattacharyya S, Ghosh S, Jhonson PL, Bhattacharya SK, Majumdar S (2001) Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events. Infect Immun 69:1499-1507 (Pubitemid 32187601)
8. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H (1992) Establishment of stable, cell mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539-542
9. Carrión J, Nieto A, Iborra S, Iniesta V, Soto M, Folgueira C, Abanades DR, Requena JM, Alonso C (2006) Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunol 28:173-183
10. Coelho EA, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, Rodrigues RC, Charest H, Matlashewski G, Gazzinelli RT, Fernandes AP (2003) Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun 71:988-994
11. Engwerda CR, Kaye PM (2000) Organ-specific immune responses associated with infectious disease. Immunol Today 21:73-78 (Pubitemid 30069619)
12. Garcia-Alonso M, Nieto CG, Blanco A, Requena JM, Alonso C, Navarrete I (1996) Presence of antibodies in the aqueous humour and cerebrospinal fluid during Leishmania infections in dogs. Pathological features at the central nervous system. Parasite Immunol 18:539-546 (Pubitemid 26382364)
13. Garg R, Dube A (2006) Animal models for vaccine studies for visceral leishmaniasis. Indian J Med Res 123:439-454 (Pubitemid 43905581)
14. Himmelrich H, Launois P, Maillard I, Biedermann T, Tacchini-Cottier F, Locksley RM (2000) In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J Immunol 164:4819-4825 (Pubitemid 30238085)
15. Iniesta V, Gomez-Nieto LC, Corraliza I (2001) The inhibition of arginase by N(omega)-hydroxy-1-Arginine controls the growth of Leishmania inside macrophages. J Exp Med 193:777-784
16. Iniesta V, Gómez-Nieto LC, Molano I, Mohedano A, Carcelén J, Mirón C, Alonso C, Corraliza I (2002) Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol 24:113-118 (Pubitemid 34451222)
17. Kaur S, Kaur T, Garg N, Mukherjee S, Raina P, Athokpam V (2008) Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis. Parasitol Res 103:1413-1419
18. Kaye PM, Gorak P, Murphy M, Ross S (1995) Strategies for immune intervention in visceral leishmaniasis. Ann Trop Med Parasitol 89:75-81 (Pubitemid 26030070)
19. Keenan CM, Hendricks LD, Lightner L, Johnson AJ (1984) Visceral leishmaniasis in the German shepherd dog. I. Infection, clinical disease, and clinical pathology. Vet Pathol 21:74-79
20. Lehmann J, Enssle KH, Lehmann I, Emmendorfer A, Lohmann-Matthes ML (2000) The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice. J Interferon Cytokine Res 20:63-77 (Pubitemid 30067490)
21. Malafaia G, Serafim TD, Silva ME, Pedrosa ML, Rezende SA (2009) Protein-energy malnutrition decreases immune response toLeishmania chagasi vaccine in BALB/c mice. Parasite Immunol 3:41-49
22. McMahon-Pratt D, Alexander J (2004) Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniasis or the visceral disease? Immunol Rev 201:206-224 (Pubitemid 39318454)
23. Melby PC,Yang YZ, Cheng J, ZhaoW(1998) Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani. Infect Immun 66:18-27 (Pubitemid 28018796)
24. Melby PC, Tabares A, Restrepo BI, Cardona AE, McGuff HS, Teale JM (2001a) Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Exp Parasitol 99:17-25 (Pubitemid 33116623)
25. Melby PC, Chandrasekar B, Zhao W, Coe JE (2001b) The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent th1-like cytokine response. J Immunol 166:1912-1920 (Pubitemid 32114678)
26. Muigai R, Gatei DG, Shaunak S, Wozniak A, Bryceson AD (1983) Jejunal function and pathology in visceral leishmaniasis. Lancet 2:476-479 (Pubitemid 13039999)
27. Mukherjee P, Ghosh AK, Ghose AC (2003) Infection pattern and immune response in the spleen and liver of BALB/c mice intracardially infected with Leishmania donovani amastigotes. Immunol Letters 86:131-138 (Pubitemid 36324273)
28. Murphy ML, Wille U, Villegas EN, Hunter CA, Farrell JP (2001) IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol 31:2848-2856 (Pubitemid 32994535)
29. Murray HW, Stern JJ, Welte K, Rubin BY, Carriero SM, Nathan CF (1987) Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin-2 and interferon-gamma. J Immunol 138:2290-2297 (Pubitemid 17046286)
30. Murray HW, Squires KE, Miralles CD, Stoeckle MY, Granger AM, Granelli-Piperno A, Bogdan C (1992) Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J Immunol 148:1858-1863
31. Nieto CG, Viñuelas J, Blanco A, Garcia-Alonso M, Verdugo SG, Navarrete I (1996) Detection of Leishmania infantum amastigotes in canine choroid plexus. Vet Rec 139:346-347 (Pubitemid 126628855)
32. Peters N, Sacks D (2006) Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 213:159-179 (Pubitemid 44401500)
33. Prasad LS, Sen S (1996) Migration of Leishmania donovani amastigotes in the cerebrospinal fluid. Am J Trop Med Hyg 55:652-654 (Pubitemid 27111002)
34. Ramos CC, Duarte MI, Ramos AM (1994) Fatal visceral leishmaniasis associated with acquired immunodeficiency syndrome: report of a case with necropsy findings and immunohistochemical study. Rev Soc Bras Med Trop 27:245-250
35. Requena JM, Iborra S, Carrion J, Alonso C, Soto M (2004) Recent advances in vaccines for leishmaniasis. Expert Opin Biol Theraphy 4:1505-1517 (Pubitemid 39222982)
36. Rhodes SG, Graham SP (2002) Is 'timing' important for cytokine polarization? Trends Immunol 23:246-249 (Pubitemid 34499561)
37. Rolao N, Melo C, Campino L (2004) Influence of the inoculation route in BALB/c mice infected by Leishmania infantum. Acta Trop 90:123-126 (Pubitemid 38117061)
38. Sacks DL, Melby PC (2001) Animal models for the analysis of immune responses to leishmaniasis. Curr Protoc Immunol 19: Unit 19.2
39. Stäger S, Joshi T, Bankoti R (2010) Immune evasive mechanisms contributing to persistent Leishmania donovani infection. Immunol Res 47:14-24
40. Toumanen E (1996) Entry of pathogens into the central nervous system. FEMS Microbiol Rev 18:289-299
41. Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P (1996) Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol 157:827-835 (Pubitemid 26231389)
42. Viñuelas J, Garcia-Alonso M, Fernando L, Navarrete I, Molano I, Mirón C, Carcelén J, Alonso C, Nieto CG (2001) Meningeal leishmaniosis induced by Leishmania infantum in naturally infected dogs. Vet Parasitol 101:23-27 (Pubitemid 32918315)
43. Wilson ME, Jeronimo SM, Pearson RD (2005) Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog 38:147-160 (Pubitemid 40417730)
44. Yazdanbakhsh M, Sacks DL (2010) Why does immunity to parasites take so long to develop? Nat Rev Immunol 10:80-81
45. Zanin FH, Coelho EA, Tavares CA, Marques-da-Silva EA, Costa MMS, Rezende SA, Gazzinelli RT, Fernandes AP (2007) Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections. Microbes Infect 9:1070-1077 (Pubitemid 47287743)